Guyana vs Mexico: Access to anti-retroviral drugs, male
Guyana
66.0%
in 2024
Mexico
67.0%
in 2024
Guyana rank
80th
Mexico rank
78th
Access to anti-retroviral drugs, male over time
- Guyana
- Mexico
How they compare
Mexico currently reports 67.0% against 66.0% in Guyana, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Mexico ahead.
Guyana ranks 80th and Mexico ranks 78th of 141 countries.
Across the 3 decades both report, Guyana averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | Guyana | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.4% | 20.0% | 3.6% | Mexico |
| 2010s | 49.2% | 40.3% | 8.9% | Guyana |
| 2020s | 60.8% | 63.2% | 2.4% | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Guyana or Mexico?
- Mexico, at 67.0% against 66.0% in Guyana as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Guyana and Mexico?
- 1.0%, with Mexico ahead.
- How many years of comparable data are there for Guyana and Mexico?
- 25 years are reported by both, from 2000 to 2024.
- How do Guyana and Mexico rank globally for access to anti-retroviral drugs, male?
- Guyana ranks 80th and Mexico ranks 78th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.